Provided by Tiger Trade Technology Pte. Ltd.

IMMUNOTECH-B

0.400
-0.015-3.61%
Volume:103.00K
Turnover:42.06K
Market Cap:247.20M
PE:-0.95
High:0.410
Open:0.410
Low:0.400
Close:0.415
52wk High:5.400
52wk Low:0.330
Shares:618.00M
HK Float Shares:618.00M
Volume Ratio:1.41
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.420
ROE:-242.61%
ROA:-20.57%
PB:-2.52
PE(LYR):-0.95
PS:- -

Loading ...

Investment Outlook from IT Expert: Bullish Momentum for Innovative Drugs and Their Supply Chain in Second Half of the Year

Deep News
·
Aug 06

Renewed Momentum in Innovative Drugs: Fleeting Sentiment or Confirmation of an Industry Turning Point?

Deep News
·
Aug 06

Haisco Pharmaceutical Wins Approval for New Migraine Drug Trial

Stock News
·
Aug 06

Building a Layered Coordination System Between Social and Commercial Insurance to Solve Innovative Drug Payment Challenges

Deep News
·
Aug 06

HENGRUI PHARMA's Zhang Lianshan: Global Strategy at a Turning Point, Innovative Drug Firms Must Ultimately Go Global Independently

Deep News
·
Aug 06

Medical Insurance Covers 5,890 Drugs, Accelerating Access for Innovative Medicines

Deep News
·
Aug 05

Pharmaceutical Innovation Chain Surges Across the Board; CXO Giant Reports First Half-Year Net Profit Exceeding 10 Billion Yuan, Soaring Over 10% Post-Earnings; Innovative Drug Leader Rebounds, 520880 Rises 2.58% on Volume

Deep News
·
Aug 04

Top-tier financial institutions actively recommend this major biotech stock, with a market cap of 390 billion yuan, as significant positive catalysts emerge

Deep News
·
Aug 03

Immunotech Biopharm posts stable July 2026 share capital at 617.50 million shares; RMB270 million convertibles remain outstanding

Bulletin Express
·
Aug 03

First Half of 2026 Sees Major Surge in Innovative Drug Financing; Hong Kong Stock Connect Innovative Drug ETF Huabao (520880) Trades at Premium Amid Range-Bound Declines, CICC Says Higher Probability of Recovery

Deep News
·
Aug 03

Unraveling the Second Half Investment Strategy for Innovative Drugs: An Analysis by Great Wall Fund Manager Liang Furui

Deep News
·
Jul 31

Bio-Thera Faces Another 300 Million Yuan Loss as Drug Development Costs Strain Cash Reserves

Deep News
·
Jul 31

Hong Kong Stock Movers: Several Innovative Drug Stocks Rally in Afternoon Trading, GENSCRIPT BIO Surges Nearly 8%, REMEGEN Gains Over 4%

Stock News
·
Jul 31

Clinical Progress Accelerates, But Cash Burn Remains the Unanswered Question for 18A Biotech Innovator

Stock News
·
Jul 31

China's domestic innovative drugs set for overseas revenue breakthrough as policy support strengthens

Stock News
·
Jul 31

Innovative Drugs May Enter an Era of Dual Commercial Insurance Coverage Lists

Deep News
·
Jul 30

Innovative Drug BD Deals Surpass 100 Billion in First Half, Signaling a Positive Long-Term Trend?

Deep News
·
Jul 29

Innovative Drug Sector Attracts Attention with Reasonable Valuations and Strong Investment Appeal

Deep News
·
Jul 29

Domestic Innovation Drugs Accelerate Dual-Track Growth: First Chinese Launches and Overseas Dealmaking Surge - T+0 Huatai-PineBridge Hang Seng Innovation Drug ETF (520500) Attracts Over 1.6 Billion Yuan in Net Inflows This Year

Deep News
·
Jul 29

Innovative Drugs Emerge as a New Pillar Industry, Using ICBC Credit Suisse ETF Matrix to Anchor Core Assets

Deep News
·
Jul 28